We also discuss potential strategies to deal with drug resistance. Slow transport via folate receptor (lower affinity for methotrexate than for folic acid) Increased drug efflux via ATP-binding ...

Elite Pharmaceuticals Inc (ELTP) reports significant revenue increases and successful product launches, despite facing competitive and regulatory challenges.

chiron has developed an advanced organ-on chip technology, which comprises placing of human cells on chips - eg. cells present in the joint - to test the efficacy of drugs. This ground-breaking ...

Amgen today announced the presentation of new data across its rare disease portfolio and pipeline at the annual American College of Rheumatology (ACR) Convergence 2024 conference in Washington, D.C., ...

The central repository of the drug and medication centre helps to navigate to different sections. Medindia's platform provides carefully curated details on generics, brand names, side-effects ...

The Food and Drug Administration (FDA) has expanded the approval of Jylamvo (methotrexate) to include the treatment of pediatric patients with acute lymphoblastic leukemia (ALL), as part of a ...

Objectives Secondary prevention of rheumatoid arthritis (RA) is generally considered potentially impactful because the entire ...

The quality of dietary supplements varies, and they aren’t regulated like drugs by the US Food and Drug Administration ...

Shares of Elite Pharmaceuticals, Inc. ELTP have gained 12.2% since the company released its earnings for the quarter ended ...

Q2 2025 Earnings Conference Call November 15, 2024 11:30 AM ET. Company Participants. Nasrat Hakim - President and CEO Carter Ward - CFO.

Stelara (ustekinumab) is a prescription injection that’s used to treat certain autoimmune conditions, such as plaque psoriasis. Stelara can cause side effects that range from mild to serious.